Pregled bibliografske jedinice broj: 1194201
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug // Nature Communications, 6 (2015), 8466, 16 doi:10.1038/ncomms9466 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1194201 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Structural and functional rejuvenation of the aged
brain by an approved anti-asthmatic drug
Autori
Marschallinger, Julia ; Schäffner, Iris ; Klein, Barbara ; Gelfert, Renate ; Rivera, Francisco J. ; Illes, Sebastian ; Grassner, Lukas ; Janssen, Maximilian ; Rotheneichner, Peter ; Schmuckermair, Claudia ; Coras, Roland ; Boccazzi, Marta ; Chishty, Mansoor ; Lagler, Florian B. ; Renic, Marija ; Bauer, Hans-Christian ; Singewald, Nicolas ; Blümcke, Ingmar ; Bogdahn, Ulrich ; Couillard-Despres, Sebastien ; Lie, D. Chichung ; Abbracchio, Maria P. ; Aigner, Ludwig
Izvornik
Nature Communications (2041-1723) 6
(2015);
8466, 16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
aging
Sažetak
As human life expectancy has improved rapidly in industrialized societies, age-related cognitive impairment presents an increasing challenge. Targeting histopathological processes that correlate with age-related cognitive declines, such as neuroinflammation, low levels of neurogenesis, disrupted blood–brain barrier and altered neuronal activity, might lead to structural and functional rejuvenation of the aged brain. Here we show that a 6-week treatment of young (4 months) and old (20 months) rats with montelukast, a marketed anti-asthmatic drug antagonizing leukotriene receptors, reduces neuroinflammation, elevates hippocampal neurogenesis and improves learning and memory in old animals. By using gene knockdown and knockout approaches, we demonstrate that the effect is mediated through inhibition of the GPR17 receptor. This work illustrates that inhibition of leukotriene receptor signalling might represent a safe and druggable target to restore cognitive functions in old individuals and paves the way for future clinical translation of leukotriene receptor inhibition for the treatment of dementias.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
- Nature Index